Trinity Biotech plc (TRIB)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Clinical Laboratory Goods		39.37M	42.29M	46.04M	-	84.28M
Clinical Laboratory Goods Growth		-6.90%	-8.14%	-	-	-
Clinical Laboratory Services		4.75M	5.45M	7.27M	-	8.49M
Clinical Laboratory Services Growth		-12.89%	-25.01%	-	-	-
Point-Of-Care Products		17.43M	9.09M	9.21M	-	9.22M
Point-Of-Care Products Growth		91.76%	-1.32%	-	-	-
Total		61.56M	56.83M	62.52M	-	101.98M
Total Growth		8.31%	-9.10%	-	-	12.77%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Americas		61.61M	66.85M	76.62M	116.31M	136.99M
Americas Growth		-7.84%	-12.75%	-34.12%	-15.10%	32.22%
Rest of World – Ireland		20.47M	12.72M	25.10M	28.23M	25.39M
Rest of World – Ireland Growth		60.89%	-49.32%	-11.10%	11.21%	-9.39%
Eliminations		-20.52M	-22.74M	-26.94M	-51.58M	-60.40M
Total		61.56M	56.83M	74.78M	92.97M	101.98M
Total Growth		8.31%	-24.00%	-19.56%	-8.84%	12.77%

Source: S&P Global Market Intelligence.